PP
ABBV icon

Patron Partners’s AbbVie ABBV Stock Holding History

Patron Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.35M Buy
9,349
+538
+6% +$116K 0.9% 28
2026
Q1 		$1.92M Buy
8,811
+760
+9% +$169K 0.85% 28
2025
Q4 		$1.84M Sell
8,051
-43
-0.5% -$9.79K 0.82% 29
2025
Q3 		$1.87M Buy
8,094
+426
+6% +$86.8K 0.85% 27
2025
Q2 		$1.42M Buy
7,668
+60
+0.8% +$11.2K 0.7% 35
2025
Q1 		$1.59M Buy
7,608
+400
+6% +$77.8K 0.86% 23
2024
Q4 		$1.28M Buy
7,208
+618
+9% +$114K 0.69% 34
2024
Q3 		$1.3M Sell
6,590
-52
-0.8% -$9.71K 0.72% 32
2024
Q2 		$1.14M Sell
6,642
-1,081
-14% -$179K 0.67% 33
2024
Q1 		$1.41M Sell
7,723
-1,441
-16% -$248K 0.86% 27
2023
Q4 		$1.42M Sell
9,164
-3,872
-30% -$565K 0.94% 21
2023
Q3 		$1.94M Buy
13,036
+154
+1% +$22.6K 1.43% 11
2023
Q2 		$1.74M Sell
12,882
-288
-2% -$42.2K 1.23% 15
2023
Q1 		$2.1M Sell
13,170
-177
-1% -$27.1K 1.55% 11
2022
Q4 		$2.16M Buy
13,347
+255
+2% +$39.1K 1.62% 9
2022
Q3 		$1.76M Buy
13,092
+56
+0.4% +$8.04K 1.46% 11
2022
Q2 		$2M Buy
13,036
+299
+2% +$45.7K 1.59% 9
2022
Q1 		$2.06M Buy
12,737
+297
+2% +$43.1K 1.41% 10
2021
Q4 		$1.68M Buy
12,440
+627
+5% +$74.1K 1.1% 13
2021
Q3 		$1.27M Buy
11,813
+112
+1% +$12.8K 0.94% 19
2021
Q2 		$1.32M Buy
11,701
+959
+9% +$108K 0.99% 14
2021
Q1 		$1.16M Buy
10,742
+1,530
+17% +$164K 0.98% 14
2020
Q4 		$987K Buy
+9,212
New +$885K 0.95% 15

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Patron Partners's ABBV Position: Q2 2026 in Review

Patron Partners increased its AbbVie (ABBV) stake by 6.1% in Q2 2026, buying an estimated $116K and bringing the position to 9,349 shares worth $2.35M. The position accounts for 0.9% of the portfolio, ranked #28.

Patron Partners first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Patron Partners held 9,349 shares of AbbVie worth $2.35M as of Q2 2026.
  • Patron Partners bought 538 AbbVie shares in Q2 2026, an estimated $116K.
  • AbbVie made up 0.9% of Patron Partners's portfolio in Q2 2026, its #28 holding.
  • Patron Partners first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Patron Partners's 13F filing for Q2 2026, filed 11 Aug 2026.